Harvard Medical School’s Executive Education program invites you to join Harvard medical faculty and industry leaders to discuss potential changes in national health policy and the effects on the healthcare industry. What do we need to know? What changes are anticipated? How might industry respond? We will explain the current landscape and potential scenarios the country might face in the future.
Date: Thursday March 2nd, 2017 – 5:30pm cocktails, 6:15-8:15pm program
Location: Harvard Medical School Campus – Longwood Avenue, Boston (Room TBD)
Registration: $50 (includes parking, cocktails & hors d’oeuvres)
James Capretta is a resident fellow and holds the Milton Friedman Chair at the American Enterprise Institute, where he studies health care, entitlements, and US budgetary policy, as well as global trends in aging, health, and retirement programs. He recently directed a major study on reforming US health care according to market principles and consumer choice.
Katrine Bosley is the CEO of Editas Medicine, and has been part of the biotechnology industry for over 25 years. Before Editas, she was an Entrepreneur-in-Residence at The Broad Institute, President and CEO of Avila Therapeutics, and has served in senior roles at Adnexus Therapeutics, Biogen and Highland Capital Partners. Katrine also currently serves as Chairman of the Board of Genocea Biosciences (NASDAQ: GNCA) and is a Board member of Galapagos NV (EURONEXT and NASDAQ: GLPG), of Scholar Rock, LLC, and of BIO – the Biotechnology Innovation Organization.
David Cutler is the Otto Eckstein Professor of Applied Economics and a Harvard College Professor. Professor Cutler was a key advisor in the formulation of recent cost control legislation in Massachusetts, and is one of the members of the Health Policy Commission created to help reduce medical spending.
Michael Chernew is the Leonard D. Schaeffer Professor of Health Care Policy and the director of the Healthcare Markets and Regulation (HMR) Lab in the HMS Department of Health Care Policy. Professor Chernew’s work has focused on Value-Based Insurance Design (VBID), payment reform, and cost and quality variation.
Read more about the event and register here!